158 related articles for article (PubMed ID: 26185947)
1. Late-onset Epstein-Barr virus-related disease in acute leukemia patients after haploidentical hematopoietic stem cell transplantation is associated with impaired early recovery of T and B lymphocytes.
Liu J; Yan C; Zhang C; Xu L; Liu Y; Huang X
Clin Transplant; 2015 Oct; 29(10):904-10. PubMed ID: 26185947
[TBL] [Abstract][Full Text] [Related]
2. Association of Epstein-Barr virus reactivation with the recovery of CD4/CD8 double-negative T lymphocytes after haploidentical hematopoietic stem cell transplantation.
Bian Z; Liu J; Xu LP; Chang YJ; Wang Y; Zhang XH; Huang XJ
Bone Marrow Transplant; 2017 Feb; 52(2):264-269. PubMed ID: 27797369
[TBL] [Abstract][Full Text] [Related]
3. Inverse correlation of Vδ2
Liu J; Bian Z; Wang X; Xu LP; Fu Q; Wang C; Chang YJ; Wang Y; Zhang XH; Jiang Z; Huang XJ
Br J Haematol; 2018 Jan; 180(2):276-285. PubMed ID: 29270985
[TBL] [Abstract][Full Text] [Related]
4. Differential impact of two doses of antithymocyte globulin conditioning on lymphocyte recovery upon haploidentical hematopoietic stem cell transplantation.
Liu J; Xu LP; Bian Z; Chang YJ; Wang Y; Zhang XH; Huang XJ
J Transl Med; 2015 Dec; 13():391. PubMed ID: 26715367
[TBL] [Abstract][Full Text] [Related]
5. Immune reconstitution after T-cell replete HLA haploidentical hematopoietic stem cell transplantation using high-dose post-transplant cyclophosphamide.
Maeda Y
J Clin Exp Hematop; 2021 Mar; 61(1):1-9. PubMed ID: 33551435
[TBL] [Abstract][Full Text] [Related]
6. Joint Modeling of Immune Reconstitution Post Haploidentical Stem Cell Transplantation in Pediatric Patients With Acute Leukemia Comparing CD34
Salzmann-Manrique E; Bremm M; Huenecke S; Stech M; Orth A; Eyrich M; Schulz A; Esser R; Klingebiel T; Bader P; Herrmann E; Koehl U
Front Immunol; 2018; 9():1841. PubMed ID: 30154788
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
8. Reconstitution of lymphocyte subpopulations after hematopoietic stem cell transplantation: comparison of hematologic malignancies and donor types in event-free patients.
Park BG; Park CJ; Jang S; Chi HS; Kim DY; Lee JH; Lee JH; Lee KH
Leuk Res; 2015 Dec; 39(12):1334-41. PubMed ID: 26422556
[TBL] [Abstract][Full Text] [Related]
9. Immune reconstitution of HLA-A*0201/BMLF1- and HLA-A*1101/LMP2-specific Epstein Barr virus cytotoxic T lymphocytes within 90 days after haploidentical hematopoietic stem cell transplantation.
Zhou L; Lu DP
Virol J; 2019 Feb; 16(1):19. PubMed ID: 30736814
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy followed by modified donor lymphocyte infusion as a treatment for relapsed acute leukemia after haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: superior outcomes compared with chemotherapy alone and an analysis of prognostic factors.
Yan CH; Wang JZ; Liu DH; Xu LP; Chen H; Liu KY; Huang XJ
Eur J Haematol; 2013 Oct; 91(4):304-14. PubMed ID: 23837640
[TBL] [Abstract][Full Text] [Related]
11. Graft manipulation and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation from mismatched unrelated and mismatched/haploidentical related donors in pediatric leukemia patients.
Gonzalez-Vicent M; Perez A; Abad L; Sevilla J; Ramirez M; Diaz MA
J Pediatr Hematol Oncol; 2010 Apr; 32(3):e85-90. PubMed ID: 20216238
[TBL] [Abstract][Full Text] [Related]
12. Comparison of clinical outcomes between unrelated single umbilical cord blood and "ex-vivo" T-cell depleted haploidentical transplantation in children with hematological malignancies.
Gómez-Santos C; González-Vicent M; Molina B; Deltoro N; Herrero B; Ruiz J; Pérez-Martínez A; Diaz MA
World J Pediatr; 2021 Dec; 17(6):609-618. PubMed ID: 34590210
[TBL] [Abstract][Full Text] [Related]
13. Mismatched T cell-depleted hematopoietic stem cell transplantation for children with high-risk acute leukemia.
Aversa F; Terenzi A; Felicini R; Tabilio A; Falzetti F; Carotti A; Falcinelli F; Sodani P; Amici A; Zucchetti P; Mazzarino I; Martelli MF
Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S29-32. PubMed ID: 9989886
[TBL] [Abstract][Full Text] [Related]
14. Varicella zoster reactivation after hematopoietic stem cell transplant in children is strongly correlated with leukemia treatment and suppression of host T-lymphocyte immunity.
Vermont CL; Jol-van der Zijde EC; Hissink Muller P; Ball LM; Bredius RG; Vossen AC; Lankester AC
Transpl Infect Dis; 2014 Apr; 16(2):188-94. PubMed ID: 24438482
[TBL] [Abstract][Full Text] [Related]
15. Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery.
Kalwak K; Gorczyńska E; Toporski J; Turkiewicz D; Slociak M; Ussowicz M; Latos-Grazyńska E; Król M; Boguslawska-Jaworska J; Chybicka A
Br J Haematol; 2002 Jul; 118(1):74-89. PubMed ID: 12100130
[TBL] [Abstract][Full Text] [Related]
16. Peripheral blood lymphocyte and monocyte recovery and survival in acute leukemia postmyeloablative allogeneic hematopoietic stem cell transplant.
Thoma MD; Huneke TJ; DeCook LJ; Johnson ND; Wiegand RA; Litzow MR; Hogan WJ; Porrata LF; Holtan SG
Biol Blood Marrow Transplant; 2012 Apr; 18(4):600-7. PubMed ID: 21843495
[TBL] [Abstract][Full Text] [Related]
17. Examining the origin of posttransplant lymphoproliferative disorder in a patient after a second allogeneic hematopoeitic stem cell transplantation for relapsed BCR-ABL positive acute lymphoblastic leukemia.
Ruf S; Moser O; Wössmann W; Kreyenberg H; Wagner HJ
J Pediatr Hematol Oncol; 2011 Jan; 33(1):50-4. PubMed ID: 21178708
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
[TBL] [Abstract][Full Text] [Related]
19. Improved immune recovery after transplantation of TCRαβ/CD19-depleted allografts from haploidentical donors in pediatric patients.
Lang P; Feuchtinger T; Teltschik HM; Schwinger W; Schlegel P; Pfeiffer M; Schumm M; Lang AM; Lang B; Schwarze CP; Ebinger M; Urban C; Handgretinger R
Bone Marrow Transplant; 2015 Jun; 50 Suppl 2():S6-10. PubMed ID: 26039210
[TBL] [Abstract][Full Text] [Related]
20. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype.
Aversa F; Tabilio A; Velardi A; Cunningham I; Terenzi A; Falzetti F; Ruggeri L; Barbabietola G; Aristei C; Latini P; Reisner Y; Martelli MF
N Engl J Med; 1998 Oct; 339(17):1186-93. PubMed ID: 9780338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
